![Ophir Shahaf](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ophir Shahaf
Directeur/Membre du Conseil chez
MERCHAVIA HOLDINGS AND INVESTMENTS LTD
Profil
Ophir Shahaf is currently a Director at Merchavia Holdings & Investments Ltd. since 2019 and a Partner at eHealth Ventures Israel Ltd. since 2015.
Previously, he served as the Chief Executive Officer at HBL- Hadasit Bio-Holdings Ltd. and Hadasit Bio-Holdings Ltd. from 2007 to 2013.
He also held positions as a Director at Thrombotech Ltd., KAHR Medical Ltd., Bio-MarCare Technologies Ltd., Vice President & General Counsel at Clal Biotechnology Industries Ltd., and Vice President-Business Development at Protalix Biotherapeutics Ltd. Mr. Shahaf holds an MBA from New York University, a graduate degree from Tel-Aviv University, and an MBA from The Leonard N Stern School of Business.
Postes actifs de Ophir Shahaf
| Sociétés | Poste | Début |
|---|---|---|
| MERCHAVIA HOLDINGS AND INVESTMENTS LTD | Directeur/Membre du Conseil | 14/03/2019 |
Ehealth Ventures Israel Ltd.
 Ehealth Ventures Israel Ltd. Investment ManagersFinance eHealth Ventures invests in companies located in Israel. The firm focuses on broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Private Equity Investor | 01/11/2015 |
Anciens postes connus de Ophir Shahaf
| Sociétés | Poste | Fin |
|---|---|---|
Hadasit Bio-Holdings Ltd. /Private Equity/
 Hadasit Bio-Holdings Ltd. /Private Equity/ Investment ManagersFinance Hadasit Bio-Holdings /Private Equity/ invests in both public and private companies located in Israel. The firm focuses on biotechnology sectors such as immuno-oncology, ophthalmology, and inflammatory diseases. It participates in buyout transactions. The firm acquires minority interests. | Directeur Général | 31/12/2013 |
Thrombotech Ltd.
 Thrombotech Ltd. Medical SpecialtiesHealth Technology Develops drugs that prevent and treat acute thromboembolic events | Directeur/Membre du Conseil | - |
Bio-MarCare Technologies Ltd.
 Bio-MarCare Technologies Ltd. Medical/Nursing ServicesHealth Services Develops diagnostic kits based on novel biomarkers for early cancer identification, monitoring and assistance | Directeur/Membre du Conseil | 02/01/1901 |
KAHR Medical Ltd.
 KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic drugs | Directeur/Membre du Conseil | - |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Conseiller Juridique Général | - |
Formation de Ophir Shahaf
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Clal Biotechnology Industries Ltd.
 Clal Biotechnology Industries Ltd. Financial ConglomeratesFinance Provides investment and support services for life science research companies | Finance |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protalix Biotherapeutics Ltd.
 Protalix Biotherapeutics Ltd. BiotechnologyHealth Technology Developes a proprietary plant cell culture technology and innovative bioreactor system | Health Technology |
HBL- Hadasit Bio-Holdings Ltd.
 HBL- Hadasit Bio-Holdings Ltd. Investment ManagersFinance Provides investment services in research and development companies for the medical & biotechnology sectors | Finance |
Hadasit Bio-Holdings Ltd. /Private Equity/
Hadasit Bio-Holdings Ltd. /Private Equity/ Investment ManagersFinance Hadasit Bio-Holdings /Private Equity/ invests in both public and private companies located in Israel. The firm focuses on biotechnology sectors such as immuno-oncology, ophthalmology, and inflammatory diseases. It participates in buyout transactions. The firm acquires minority interests. | Finance |
Thrombotech Ltd.
Thrombotech Ltd. Medical SpecialtiesHealth Technology Develops drugs that prevent and treat acute thromboembolic events | Health Technology |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic drugs | Health Technology |
Merchavia Holdings & Investments Ltd.
 Merchavia Holdings & Investments Ltd. Financial ConglomeratesFinance Operates as holding company which engages in investments in medical technologies, biomed and life sciences & wholesales medical products | Finance |
Bio-MarCare Technologies Ltd.
Bio-MarCare Technologies Ltd. Medical/Nursing ServicesHealth Services Develops diagnostic kits based on novel biomarkers for early cancer identification, monitoring and assistance | Health Services |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ehealth Ventures Israel Ltd.
Ehealth Ventures Israel Ltd. Investment ManagersFinance eHealth Ventures invests in companies located in Israel. The firm focuses on broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Finance |
Choisissez Zonebourse 
